Performance of the 2023 ACR/EULAR classification criteria for antiphospholipid syndrome in a Mexican cohort.

Erik Cimé-AkéGabriela Hernández-MolinaAmaya Llorente-ChávezEduardo Martín-Nares

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2024)

In both PAPS and SAPS, the 2023 AECC have higher specificity than the 2006 RSCC. The main feature of PAPS patients according to the 2023 AECC was thrombosis. These criteria might identify patients at higher risk of thrombosis and damage accrual.

Keyphrases

machine learning
pulmonary embolism
end stage renal disease
deep learning
ejection fraction
newly diagnosed
oxidative stress